Biora Therapeutics (BIOR) to Release Quarterly Earnings on Tuesday

Biora Therapeutics (NASDAQ:BIOR) is anticipated to issue its quarterly earnings data after the market closes on Tuesday, March 25th. Analysts expect the company to announce earnings of ($3.30) per share and revenue of $0.23 million for the quarter.

Biora Therapeutics Price Performance

BIOR stock opened at $0.13 on Friday. Biora Therapeutics has a 1-year low of $0.15 and a 1-year high of $13.30. The business has a fifty day moving average price of $0.15 and a 200-day moving average price of $2.10. The stock has a market capitalization of $589,799.20, a P/E ratio of -0.01 and a beta of 1.12.

About Biora Therapeutics

Biora Therapeutics, Inc, a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases.